Document is current
Any future updates will be listed below
-
Authors
Liu, Si-Yang
Chen, Qixun
Zhou, Chengzhi
Zhang, Huizhong
Li, Wen
Chen, Jianhua
Hu, Jian
Wu, Lin
Chen, Qunqing
Dai, Qiangsheng
Shan, Jian-Zhen
Xu, Fei
Liu, Si-Yang Maggie
Wu, Yi-Long
-
Funding
Funding for this research was provided by:
The study was funded by Chinese Thoracic Oncology Group (CTONG2004)
- License Information
-
More Information
Article History
Received: 5 August 2022
Accepted: 13 February 2023
First Online: 5 March 2023
Declarations
:
: Prof. Yi-Long Wu reports personal financial interests: consulting and advisory services, speaking engagements of Roche, AstraZeneca, Eli Lilly, Boehringer Ingelheim, Sanofi, MSD, BMS. The other authors declare that they have no competing interests.
: Prof. Yi-Long Wu reports personal financial interests: consulting and advisory services and speaking engagements for Roche, AstraZeneca, Eli Lilly, Boehringer Ingelheim, Sanofi, MSD and BMS. The other authors declare that they have no competing interests.
: The protocol and amendments were all reviewed and approved by the Independent Ethics Committee of each participating center.
: Written informed consent was obtained or waived according to the recommendation of the ethics committee of each participating center for the retrospective study.
